JPS6258166A - Method for simultaneous quantitative analysis of water-soluble vitamins in mixed vitamin preparation - Google Patents

Method for simultaneous quantitative analysis of water-soluble vitamins in mixed vitamin preparation

Info

Publication number
JPS6258166A
JPS6258166A JP60198734A JP19873485A JPS6258166A JP S6258166 A JPS6258166 A JP S6258166A JP 60198734 A JP60198734 A JP 60198734A JP 19873485 A JP19873485 A JP 19873485A JP S6258166 A JPS6258166 A JP S6258166A
Authority
JP
Japan
Prior art keywords
ion
water
soluble vitamins
vitamin preparation
mobile phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60198734A
Other languages
Japanese (ja)
Other versions
JPH071257B2 (en
Inventor
Hiroshi Ogawara
小川原 浩
Yasushi Horaguchi
洞口 靖
Masami Moroi
諸井 政己
Masao Nishimura
西村 征男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP60198734A priority Critical patent/JPH071257B2/en
Publication of JPS6258166A publication Critical patent/JPS6258166A/en
Publication of JPH071257B2 publication Critical patent/JPH071257B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

PURPOSE:To enable the quantification of water-soluble vitamins in a mixed vitamin preparation by one analysis, by subjecting the mixed vitamin preparation to an ion-pair chromatograph using a mobile phase consisting of a polar solvent, a phosphate buffer solution and an ion-pair reagent and subsequently analyzing the eluate by a fluorescent method using o-phthalaldehyde as a fluorescent reagent. CONSTITUTION:The simultaneous quantitative analysis of water-soluble vitamins in a mixed vitamin preparation can be rapidly performed with high accuracy by combining an ion-pair chromatograph method using a mobile phase consisting of a polar solvent, a phosphate buffer solution and an ion-pair reagent with a pantenol detection method according to an ortho-phthalaldehyde fluorescent method optimum to said mobile phase. As the polar solvent, methanol is especially pref. and, as the phosphate buffer solution, one with a phosphate-potassium concn. of 0.01-0.02M and pH3-3.5 is especially pref. As the ion-pair reagent, sodium pentasulfonate is especially pref.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は混合ビタミン製剤中の水溶性ビタミン類の同時
定量法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for simultaneous determination of water-soluble vitamins in mixed vitamin preparations.

なお、本明細書において、水溶性ビタミン類トは、アス
コルビン酸、塩酸チアミン、リン酸リボフラビンナトリ
ウム、塩酸ピリドキシン、ニコチン酸アミド、ノQント
テノール等のビタミンをいう。
In this specification, water-soluble vitamins refer to vitamins such as ascorbic acid, thiamine hydrochloride, sodium riboflavin phosphate, pyridoxine hydrochloride, nicotinamide, and no-Q-totenol.

〔従来の技術〕[Conventional technology]

従来、混合ビタミン製剤中のビタミン類の定量は、個々
のビタミンごとに比色法、UV法、滴定法、微生物学的
定量法等の手分析で行なわれ、多くの労力と時間を必要
とする作業であった。
Conventionally, the quantitative determination of vitamins in mixed vitamin preparations has been carried out by manual analysis using colorimetric methods, UV methods, titration methods, microbiological quantitative methods, etc. for each individual vitamin, which requires a lot of labor and time. It was work.

ところが、最近の高速液体クロマトグラフ法の技術上の
進歩と相俟って、ここ数年以内に高速液体クロマトグラ
フ法による水溶性ビタミン類の同時定量法が数多く報告
されてた〔シャーナル・オブ・ファーマシューテイカル
・サイエンス(Journal of Pharmac
euticalScience ) 70 、1014
〜1017(198i L同、70.90〜101 (
1981);同、67゜1444〜1446(1978
))。これらは充填剤にイオン交換樹脂を用いイオン交
換作用によって分離する方法と非極性充填剤を用いた逆
相クロマトグラフ法に大別できる。
However, in conjunction with recent technical advances in high-performance liquid chromatography, many methods for the simultaneous determination of water-soluble vitamins using high-performance liquid chromatography have been reported within the past few years [Sharnal of Journal of Pharmac
euticalScience) 70, 1014
~1017 (198i L same, 70.90~101 (
1981); 67° 1444-1446 (1978
)). These methods can be broadly divided into methods that use ion-exchange resins as fillers and separate by ion-exchange action, and reversed-phase chromatography methods that use non-polar fillers.

而して、近年では後者の逆相りはマドグラフ法、就中、
移動相に適当な対立イオンを加えイオン対を形成させ、
非極性固定相により分離するイオン対クロマトグラフ法
が玉流となっている。
However, in recent years, the latter reverse phase has been solved using the Madgraph method, especially,
Add appropriate opposing ions to the mobile phase to form ion pairs,
Ion-pair chromatography, which uses a non-polar stationary phase for separation, has become popular.

〔発明が解決しようとする間亀点〕[The problem that the invention is trying to solve]

しかしながら、これらの同時定量法では、上記水溶性ビ
タミンの全てを同時定量するやことはできない。すなわ
ち、水溶性の医薬品に繁用されているリン酸リボフラビ
ンナトリウムを、由来の不純物、分解物及び塩酸チアミ
ン、塩酸ピリドキシン、アスコルビン文、ニコチン酸ア
ミドから分離定量したという報告ハない。また、ノQン
トテノールについては、そのUV吸収が波長200nm
付近にあるだけで、それ以外で吸収が全くないために、
他の水溶性ビタミン類との同時6111定は困難であっ
た。
However, these simultaneous assay methods cannot simultaneously quantify all of the water-soluble vitamins mentioned above. That is, there have been no reports of separating and quantifying sodium riboflavin phosphate, which is frequently used in water-soluble pharmaceuticals, from impurities and decomposition products derived from it, as well as thiamine hydrochloride, pyridoxine hydrochloride, ascorbic acid, and nicotinic acid amide. In addition, regarding NoQ-totenol, its UV absorption is at a wavelength of 200 nm.
Because it is just nearby and there is no absorption at all other than that,
Simultaneous determination of 6111 with other water-soluble vitamins was difficult.

〔問題点を解決するための手段〕[Means for solving problems]

斯かる実状において、本発明者らは鋭意研究の結果、上
記水溶性ビタミン類の同時定量に最適な移動相を用いた
イオン対りO? )グラフ法と、この移動相に関して至
適なオルトフタルアルデヒド発蛍光による。eントテノ
ール検出法を組み合せることにより、・上記の水溶性ビ
タミン類を一括同時に、Lかも迅速かつ高精度に定量す
ることができることを見出し、本発明を完成した。
Under such circumstances, the present inventors conducted extensive research and found that the ion pair O? ) by graphical methods and optimal orthophthalaldehyde fluorescence for this mobile phase. By combining the e-totenol detection method, the present invention was completed by discovering that the above water-soluble vitamins can be simultaneously and simultaneously quantified in L quickly and with high precision.

すなわち本発明は、混合ビタミン製剤を、次の■〜■、 ■ 極性溶媒 ■ リン酸緩衝液 ■ イオン対試薬 よりなる移動相を用いたイオン対クロマトグラフに付し
、次いで溶離液を発蛍光試薬としてオルト7タルアルデ
ヒドを用いた発蛍光法により分析することを特徴とする
混合ビタミン裂剤中の水溶性ビタミン類の同時定量法を
提供するものである。
That is, in the present invention, a mixed vitamin preparation is subjected to ion pair chromatography using a mobile phase consisting of the following ■ - ■, ■ polar solvent ■ phosphate buffer ■ ion pair reagent, and then the eluent is treated with a fluorescent reagent. The present invention provides a method for simultaneous determination of water-soluble vitamins in a mixed vitamin curing agent, which is characterized by analysis by a fluorescence method using ortho-7-talaldehyde.

以下、本発明方法を、これに使用される分析装置の一例
を示す第1図と共に説明する。
Hereinafter, the method of the present invention will be explained with reference to FIG. 1, which shows an example of an analyzer used therein.

分析装置は、Aで示されるイオン対クロマトグラフと、
これに直列に接続されたBで示されるノQントテノール
検出システムよりなっている。イオン対クロマトグラフ
Aは、1で示されるカラムと2で示されるUV検出器及
び3で示される移動相等よりなるもので、通常のクロマ
トグラフと同様の構成を有する。
The analyzer includes an ion pair chromatograph indicated by A;
It consists of a no-Q totenol detection system indicated by B connected in series to this. The ion pair chromatograph A consists of a column indicated by 1, a UV detector indicated by 2, a mobile phase indicated by 3, etc., and has the same configuration as a normal chromatograph.

また、ノQントテノール検出システムBは、発蛍光試薬
としてオルトフタルアルデヒドヲ用いた発蛍光法(以下
、OPA発蛍光法という)を行なうためのB−1で示さ
れるOPA発蛍光システムとB−2で示される螢光検出
器よりなっている。OPA発蛍光システムB−1は、3
つの反応管が直列に接続したもので、ノ9ントテノール
をOPA発蛍光法により検出するためのものである。
In addition, the NoQ totenol detection system B includes an OPA fluorescence system shown as B-1 for performing a fluorescence method using ortho-phthalaldehyde as a fluorescence reagent (hereinafter referred to as OPA fluorescence method), and B- It consists of a fluorescence detector shown as 2. OPA fluorescence system B-1 is 3
Two reaction tubes are connected in series to detect non-9totenol using the OPA fluorescence method.

イオン対クロマトグラフAによるクロマト操作は常法に
従って行なうことができる。カラム1としては、シリカ
ゲル担体にオクタデシルシラン処理を施して得られるも
の、例えばTSK−GeJ  0DS−120TC東洋
曹達工業■製〕、μmボンダ、eツクC1m(米国ウォ
ーターズ社製)等が挙げられるが、就中TSK−Gej
  0DS−120Tが好ましい。
Chromatographic operations using ion pair chromatograph A can be carried out according to conventional methods. Examples of the column 1 include those obtained by treating a silica gel carrier with octadecylsilane, such as TSK-GeJ 0DS-120TC (manufactured by Toyo Soda Kogyo), μm bonder, eTsuku C1m (manufactured by Waters, USA), etc. Especially TSK-Gej
0DS-120T is preferred.

移動相3としては、リン酸緩衝液、極性溶媒及びイオン
対試薬よりなる溶液が使用される。極性溶媒としては、
エタノール、メタノール等が挙けられるが、特にメタノ
ールが好ましい。リン酸緩衝液は、水にリン酸−カリウ
ムを添加し、リン酸によってpHを調整したもので、リ
ン酸−カリウム濃度が0.01〜0.02M、  pH
が3.0〜3.5のものが特に好ましい。リン酸緩衝液
と極性溶媒の混合比率は、一般に80:20〜90:1
0となるように調整するが、極性溶媒がメタノールの場
合には84:16とするのが特に好ましい。
As the mobile phase 3, a solution consisting of a phosphate buffer, a polar solvent, and an ion pairing reagent is used. As a polar solvent,
Examples include ethanol and methanol, with methanol being particularly preferred. Phosphate buffer is made by adding potassium phosphate to water and adjusting the pH with phosphoric acid, and the concentration of potassium phosphate is 0.01 to 0.02M, pH
is particularly preferable. The mixing ratio of phosphate buffer and polar solvent is generally 80:20 to 90:1.
The ratio is adjusted to 0, but when the polar solvent is methanol, the ratio is particularly preferably 84:16.

また、イオン対試薬としては、例えばペンタンスルホン
酸ナトリウム、ヘキサンスルホン酸ナトリウム、ヘキサ
ンスルホン酸ナトリウム等が挙げられるが、就中、ペン
タンスルホン酸ナトリウムが特に好ましい。イオン対試
薬は、移動相の全組成中KO,05〜0.2w/v(%
)となるように配合するのが好ましく、この範囲以外で
は良好な分離が得られない。
Further, examples of the ion pairing reagent include sodium pentanesulfonate, sodium hexanesulfonate, sodium hexanesulfonate, etc. Among them, sodium pentanesulfonate is particularly preferred. The ion-pairing reagent is KO, 05-0.2 w/v (%) in the total composition of the mobile phase.
) is preferable, and good separation cannot be obtained outside this range.

なお、移動相は、通常1.0 m /分程度の流量で送
液される。
Note that the mobile phase is normally delivered at a flow rate of about 1.0 m/min.

またUV検出器2では、270〜280nmの波長で検
出を行なうのが好ましい。
Moreover, it is preferable that the UV detector 2 performs detection at a wavelength of 270 to 280 nm.

斯くしてイオン対り党マドグラフ分析を行ナウト、アス
コルビン酸、ニコチン酸アミド、塩!ピリドキシン、ノ
9ントテノール、塩酸チアミン、リン酸すゴフラビンナ
トリウムの順で溶出される。しかし、ノQントテノール
は、270〜280nmにUV吸収がないためここでは
検出できず、OPA発蛍光法による。Qントテノール検
出システムBによって初めて定量可能となる。
Thus, perform a Madograph analysis of ions, ascorbic acid, nicotinamide, salt! Pyridoxine, non-9totenol, thiamine hydrochloride, and sugoflavin sodium phosphate are eluted in this order. However, NoQ-totenol cannot be detected here because it has no UV absorption at 270 to 280 nm, and is therefore detected using the OPA fluorescence method. Q-totenol detection system B makes it possible to quantify it for the first time.

OPA発蛍光システムB−1は、3つの反応管を有し、
反応管aでは溶離液に一定濃度のアルカリ溶液を加え、
加温して、Qントテノールをβ−アラニンに加水分解す
る。反応管すでは、加水分触後、酸を加えて中和を行な
離液にオルトフタルアルデヒドを含有する発蛍光試液を
加えて螢光物質を生成せしめた後、螢光検出器B−2で
定量する。
OPA fluorescence system B-1 has three reaction tubes,
In reaction tube a, add a certain concentration of alkaline solution to the eluent,
Upon heating, Qtotenol is hydrolyzed to β-alanine. In the reaction tube, after hydrolysis, an acid is added to neutralize the liquid, and a fluorescent reagent containing orthophthalaldehyde is added to the syneresis to generate a fluorescent substance. Quantify with

アルカリM 7&としては、水酸化−yトリウム水溶液
が好ましく、濃度は1〜2規定とし、0.1me1分程
度の?j&tで加えるのが好ましい。
As the alkali M7&, an aqueous thorium hydroxide solution is preferable, the concentration is 1 to 2 normal, and the concentration is about 0.1me1 minute. Preferably added at j&t.

また、酸は使用したアルカリ溶液と同濃度にして同じ流
量で添加する。加水分解温度は80〜90℃が好ましく
、これ以上では例えば移動相の(j性溶媒としてメタノ
ールを用いた場合、気泡が発生し分析精度が低下してし
まう。発蛍光試液としては、0.05%オルトフタルア
ルデヒドを含むpH9,0ホウ酸緩衝液が好ましく、反
応温度は50℃程度が好ましい。発令光検出は、励起波
長345nm。
Further, the acid is added at the same concentration and at the same flow rate as the alkaline solution used. The hydrolysis temperature is preferably 80 to 90°C; if it is higher than this, for example, if methanol is used as the mobile phase solvent, bubbles will be generated and the analysis accuracy will be reduced. A pH 9.0 borate buffer containing % orthophthalaldehyde is preferred, and the reaction temperature is preferably about 50° C. The emission light is detected at an excitation wavelength of 345 nm.

検出波長455 nmで行なうのが好適である。It is preferable to carry out the detection at a wavelength of 455 nm.

なお、発蛍光試液は、通常1.0rnl/分程度の流量
で送液される。
Note that the fluorescent reagent solution is normally fed at a flow rate of about 1.0 rnl/min.

〔作用〕[Effect]

本発明に使用される移動相は、水G性ビタミン類及びそ
れら由来の不純物、分解物を良好に溶離するつまた、オ
ルトフタルアルデヒドは、との溶離液において螢光物質
への誘導体化を行なうことができる。
The mobile phase used in the present invention satisfactorily elutes water-based vitamins and their derived impurities and decomposition products, and derivatizes orthophthalaldehyde into a fluorescent substance in the eluent. be able to.

〔発明の効果〕〔Effect of the invention〕

本発明は紙上の如き方法であるため、−回の分析で製剤
中の塩酸チアミン、リン& IJボフラビンナトリウム
、アスコルビン酸、塩酸ピリドキシン、ニコチン酸アミ
ド、及びノQントテノール等の水溶性ビタミン類を定量
することが可能である。従来の高速液体クロマトグラフ
法の技術では、これらの中で同時に定量可能なものは3
成分程度が限界であり、他の成分は個々に螢光法、滴定
法、比色法等で実施しなければならなかった。従って、
本発明方法によれば、操作時間は1時間以内、精度面に
おいても98%以上の信頼率で定量分析を行なうことが
可能であり、本発明は製剤分析において非常に有効なも
のである。
Since the present invention is a paper-based method, water-soluble vitamins such as thiamin hydrochloride, phosphorus & IJ boflavin sodium, ascorbic acid, pyridoxine hydrochloride, nicotinamide, and noQ-totenol in the preparation can be determined in one analysis. It is possible to quantify. With conventional high-performance liquid chromatography technology, only three of these can be quantified simultaneously.
There was a limit to the extent of the components, and other components had to be tested individually using fluorescence methods, titration methods, colorimetric methods, etc. Therefore,
According to the method of the present invention, it is possible to perform quantitative analysis with a reliability rate of 98% or more in terms of accuracy and the operation time is within one hour, making the present invention very effective in pharmaceutical analysis.

〔実施例〕〔Example〕

次に実施例を挙げて説明する。 Next, an example will be given and explained.

実施例1 下記方法により輸液用混合ビタミン剤中の水溶性ビタミ
ン類の定量を行なった。
Example 1 Water-soluble vitamins in a mixed vitamin preparation for infusion were determined by the following method.

U) 操作法 アスコルビン酸1001f、ニコチン酸アミド20■、
塩酸ピリドキシン3翼g、塩酸チアミン10■、リン酸
リボフラビンナトリウム2■1.Qントテール5119
に対応する試料(水晶1ffi/)を正確に量り、移動
相を加えて正確に100−とじ(以下、標準溶液という
)、次の条件で液体クロマトグラフに付し、上記6成分
を同時定量する。
U) Procedure Ascorbic acid 1001f, Nicotinic acid amide 20■,
3 grams of pyridoxine hydrochloride, 10 grams of thiamine hydrochloride, 2 grams of sodium riboflavin phosphate 1. Qnttail 5119
Accurately weigh a sample (1ffi/crystal) corresponding to , add the mobile phase and precisely 100-mm (hereinafter referred to as standard solution), apply it to a liquid chromatograph under the following conditions, and simultaneously quantify the above six components. .

輸液用混合ビタミン剤についても同様に操作を行ない、
標準溶液の結果と比較する。
Perform the same procedure for the infusion vitamin mixture,
Compare with the results of the standard solution.

■)分離条件 カラム条件: TSK−Ge l  ODS −120
Tカラム管:内径41 長さ25m 移 動 相:0.01Mリン酸−カリウム溶液(pH3
,5)・メタノール(250 :50)+0.1% 1−ペンタ ンスルホン酸ナトリウム 溶出速度:1.0Wt1./分 検出波長:UV277nm カラム温度:室温 注入量=20μ! (3)  使用装置 島津LC−3A型高速液体クロマトグラフ(4)  ノ
Qントテノール検出条件 ■ 加水分解 アルカリ溶液=2N−水酸化ナトリウム流  量:0.
1−/分 反応温度:90℃ ■ 中和 酸     : 2N−塩酸 流   量:0.1m/分 反応温度:室温 ■ 発令光反応 発電光試液: 0.05 %OPA、 0.2% 2−
メルカプトエタノール、10%エ タノールを含むpH9,0ホウ酸 緩衝液 流   量:1.Ord/分 反応温度:50℃ 6) 試料(注射剤) 使用した試料は次の処方である。
■) Separation conditions Column conditions: TSK-Gel ODS-120
T column tube: inner diameter 41, length 25 m Mobile phase: 0.01M phosphate-potassium solution (pH 3
, 5) Methanol (250:50) + 0.1% Sodium 1-pentanesulfonate elution rate: 1.0Wt1. /min Detection wavelength: UV277nm Column temperature: room temperature Injection amount = 20μ! (3) Equipment used: Shimadzu LC-3A high performance liquid chromatograph (4) NoQ totenol detection conditions ■ Hydrolyzed alkaline solution = 2N-sodium hydroxide flow rate: 0.
1-/min Reaction temperature: 90℃ ■ Neutralizing acid: 2N-hydrochloric acid Flow rate: 0.1 m/min Reaction temperature: Room temperature ■ Issuing photoreaction photovoltaic test solution: 0.05% OPA, 0.2% 2-
Mercaptoethanol, pH 9.0 borate buffer containing 10% ethanol Flow rate: 1. Ord/min Reaction temperature: 50°C 6) Sample (injection) The sample used had the following formulation.

(処方) ビタミンA         10,0OOIUエルゴ
カルシフエロール   1,0OOIU酢酸トコフエロ
ール       5叩塩酸チアミン        
  50肩2リン酸り〆フラピンナトリウム     
 10mp塩酸ピリドキシン       15叩ニコ
チン酸アミド       100■ノQントテノール
         25119アスコルビン酸    
   5008F!注射用蒸留水で57!とする。
(Prescription) Vitamin A 10,000IU ergocalciferol 1,000IU tocopherol acetate 5-pound thiamine hydrochloride
50 Shoulder 2 Phosphate Frapine Sodium
10mp Pyridoxine Hydrochloride 15 Nicotinamide 100■NoQ Totenol 25119 Ascorbic Acid
5008F! 57 with distilled water for injection! shall be.

(6)本発明方法により検出した各成分のピークは第1
図の通りである。
(6) The peak of each component detected by the method of the present invention is the first
As shown in the figure.

実施例2 下記方法により内服用ビタミン剤中の水溶性ビタミン類
の定量を行なった。
Example 2 Water-soluble vitamins in internally administered vitamin preparations were determined by the following method.

(1)操作法 ニコチン酸アミド15即、塩酸チアミン1O119、リ
ン酸すゴフラピンナトリウム2即、ノ9ントテニルアル
コール3011gに対応する試料(水晶20−)を正確
に量り、移動相を加えて正確に100−とじ(以下、標
準溶液という)、次の条件で液体クロマトグラフに付し
、上記4成分を同時定量する。
(1) Procedure: Accurately weigh samples (crystal 20-) corresponding to nicotinic acid amide 15, 119 thiamine hydrochloride, sugoflavine sodium phosphate 2, and 3011 g of non-9totenyl alcohol, and add the mobile phase. The solution was subjected to liquid chromatography under the following conditions to simultaneously quantify the above four components.

り) 分離φ件 実施例1と同様。ri) Separation φ items Same as Example 1.

(3)  使用@看 実施例1と同様。(3) Use @ observation Same as Example 1.

(4)  ノQントテノール検出条件 実施例1と同様。(4) NoQ totenol detection conditions Same as Example 1.

(!19  試料(液剤) 使用した試料は次の処方である。(!19 Sample (liquid) The sample used had the following formulation.

(処方) 桂枝湯流エキス        50000哩ニンジン
キス       50.+9塩酸チアミン     
     10.9リン酸リゼフラビンナトリウム  
      2富9メチルへスベリシン       
1(1gニコチン酸アミド        15+g/
Qントテノール         30+qゾヤコウチ
/キ       0.05mゴオウチンキ     
    0.05ゴ精製水にて20rn1.とする。
(Prescription) Keishi Toryu Extract 50,000 Ginseng Kiss 50. +9 Thiamine hydrochloride
10.9 Rizeflavin Sodium Phosphate
2-rich 9-methyl hesubericin
1 (1g nicotinic acid amide 15+g/
Q Totenol 30+q Zoyakochi/Ki 0.05m Goou tincture
20rn1. with 0.05g purified water. shall be.

(6)  本発明方法により検出した各成分のピークは
第2図の通りである。
(6) The peaks of each component detected by the method of the present invention are shown in FIG.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は@成用混合ビタミン剤を本発明方法で分析した
ときのクロマトグラム、第2図は内服用ビタミン剤を本
発明方法で分析したときのクロマトグラム、第3図は本
発明方法に使用される分析装置の一例を示す概略説明図
である。 以上 第    1    図
Figure 1 is a chromatogram when a mixed vitamin preparation for human use was analyzed using the method of the present invention, Figure 2 is a chromatogram when an oral vitamin preparation was analyzed using the method of the present invention, and Figure 3 is a chromatogram when a vitamin preparation for oral use was analyzed using the method of the present invention. It is a schematic explanatory diagram showing an example of the analysis device used. Above is Figure 1

Claims (1)

【特許請求の範囲】 1、混合ビタミン製剤を、次の(1)〜(3)、(1)
極性溶媒 (2)リン酸緩衝液 (3)イオン対試薬 よりなる移動相を用いたイオン対クロマトグラフに付し
、次いで溶離液を発蛍光試薬としてオルトフタルアルデ
ヒドを用いた発蛍光法で分析することを特徴とする混合
ビタミン製剤中の水溶性ビタミン類の同時定量法。
[Scope of Claims] 1. A mixed vitamin preparation according to the following (1) to (3), (1)
It is subjected to ion pair chromatography using a mobile phase consisting of a polar solvent (2) phosphate buffer (3) ion pairing reagent, and then the eluent is analyzed by a fluorescence method using orthophthalaldehyde as a fluorescence reagent. A method for simultaneous determination of water-soluble vitamins in a mixed vitamin preparation, characterized by:
JP60198734A 1985-09-09 1985-09-09 Simultaneous determination of water-soluble vitamins in mixed vitamin preparations Expired - Lifetime JPH071257B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60198734A JPH071257B2 (en) 1985-09-09 1985-09-09 Simultaneous determination of water-soluble vitamins in mixed vitamin preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60198734A JPH071257B2 (en) 1985-09-09 1985-09-09 Simultaneous determination of water-soluble vitamins in mixed vitamin preparations

Publications (2)

Publication Number Publication Date
JPS6258166A true JPS6258166A (en) 1987-03-13
JPH071257B2 JPH071257B2 (en) 1995-01-11

Family

ID=16396093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60198734A Expired - Lifetime JPH071257B2 (en) 1985-09-09 1985-09-09 Simultaneous determination of water-soluble vitamins in mixed vitamin preparations

Country Status (1)

Country Link
JP (1) JPH071257B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06265523A (en) * 1993-03-15 1994-09-22 Hitachi Software Eng Co Ltd Apparatus and method for reading pattern of electrophoresis of gel
JP2005535605A (en) * 2002-06-04 2005-11-24 ジラ バイオテクノロジー・インク Toluidine blue O drug and its in vivo staining of dysplastic tissue and its use in chemotherapy treatment
CN102590190A (en) * 2012-01-31 2012-07-18 桂林理工大学 Method for measuring chlorogenic acid by using Fe<2+>-H2O<2-> methylene blue chemical luminescence system
CN103115981A (en) * 2013-01-29 2013-05-22 广东中烟工业有限责任公司 Quantitative detection method for riboflavin in tobacco
CN104730190A (en) * 2015-03-04 2015-06-24 苏州源泽生物技术有限公司 Method for simultaneously determining contents of plurality of types of water-soluble vitamins in foods or health products
CN114280198A (en) * 2021-12-30 2022-04-05 中国大冢制药有限公司 Vitamin B6Detection method and application of related substances thereof
CN114295736A (en) * 2021-12-02 2022-04-08 华中药业股份有限公司 Detection method of vitamin B1 impurity

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06265523A (en) * 1993-03-15 1994-09-22 Hitachi Software Eng Co Ltd Apparatus and method for reading pattern of electrophoresis of gel
JP2005535605A (en) * 2002-06-04 2005-11-24 ジラ バイオテクノロジー・インク Toluidine blue O drug and its in vivo staining of dysplastic tissue and its use in chemotherapy treatment
CN102590190A (en) * 2012-01-31 2012-07-18 桂林理工大学 Method for measuring chlorogenic acid by using Fe<2+>-H2O<2-> methylene blue chemical luminescence system
CN103115981A (en) * 2013-01-29 2013-05-22 广东中烟工业有限责任公司 Quantitative detection method for riboflavin in tobacco
CN103115981B (en) * 2013-01-29 2014-06-04 广东中烟工业有限责任公司 Quantitative detection method for riboflavin in tobacco
CN104730190A (en) * 2015-03-04 2015-06-24 苏州源泽生物技术有限公司 Method for simultaneously determining contents of plurality of types of water-soluble vitamins in foods or health products
CN104730190B (en) * 2015-03-04 2017-01-04 苏州源泽生物技术有限公司 Measure the method for multiple water-soluble vitamin content in the middle of food or health product simultaneously
CN114295736A (en) * 2021-12-02 2022-04-08 华中药业股份有限公司 Detection method of vitamin B1 impurity
CN114280198A (en) * 2021-12-30 2022-04-05 中国大冢制药有限公司 Vitamin B6Detection method and application of related substances thereof

Also Published As

Publication number Publication date
JPH071257B2 (en) 1995-01-11

Similar Documents

Publication Publication Date Title
Takatera et al. Speciation of iodo amino acids by high-performance liquid chromatography with inductively coupled plasma mass spectrometric detection
CN102812356B (en) The mass spectrography of steroid in multiple sample
Queiroz et al. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD
Elbashir et al. Recent advances in applications of capillary electrophoresis with capacitively coupled contactless conductivity detection (CE‐C4D): an update
CN104713977B (en) SPE-the liquid chromatography-tandem mass of multiple pyrazoles bactericide in grape wine
Jaime et al. Determination of paralytic shellfish poisoning toxins by high-performance ion-exchange chromatography
CN107238672B (en) The content assaying method of impurity in a kind of isoniazid or its pharmaceutical composition
Gao et al. Separation of selenium species and their sensitive determination in rice samples by ion‐pairing reversed‐phase liquid chromatography with inductively coupled plasma tandem mass spectrometry
CN102753964A (en) Mass spectrometric determination of non-derivatized, non-metabolized vitamin d
Liu et al. Determination of enoxacin and ofloxacin by capillary electrophoresis with electrochemiluminescence detection in biofluids and drugs and its application to pharmacokinetics
He et al. An online field-amplification sample stacking method for the determination of β2-agonists in human urine by CE-ESI/MS
Qi et al. Simple HPLC method for simultaneous determination of acetaminophen, caffeine and chlorpheniramine maleate in tablet formulations
JPS6258166A (en) Method for simultaneous quantitative analysis of water-soluble vitamins in mixed vitamin preparation
Yomota et al. Determination of biotin following derivatization with 2-nitrophenylhydrazine by high-performance liquid chromatography with on-line UV detection and electrospray-ionization mass spectrometry
Hadad et al. Determination of glucosamine and carisoprodol in pharmaceutical formulations by LC with pre-column derivatization and UV detection
CN105866229A (en) Method for rapidly detecting padimate in cosmetic based on ion mobility spectrometry
CN113466356A (en) Sample pretreatment and detection method for determining pesticide residue content in cow milk
CN113155991A (en) Method for rapidly determining sulfonamide antibiotics in water by full-automatic online extraction ultra-high performance liquid chromatography-tandem mass spectrometry
Hayler et al. Simple gas-liquid chromatographic method for the measurement of disopyramide in blood-plasma or serum and in urine
CN105092733B (en) The reduction method and apparatus of fixedness buffer salt content in LC MS testers
CN102944635A (en) Method for determining tris (2,3-dibromopropyl) phosphate content of water
CN105806927A (en) Quick detection method for ionic migration spectrum of 3 types of bromo or chloro salicyloyl anilines in cosmetics
Zhang et al. Simultaneous determination of toxic alkaloids in blood and urine by HPLC–ESI–MS/MS
CN104991027B (en) The method for reducing fixedness buffer salt content in LC MS testers
CN108387656B (en) Method for detecting bis (hydroxymethyl) imidazolidinyl urea in cosmetics through liquid chromatography-mass spectrometry